Malcolm Kennedy Hunt Moss

Founding Partner at Beringea LLP

Malcolm Kennedy Hunt Moss

Malcolm Kennedy Hunt Moss

Founding Partner at Beringea LLP

Overview
Career Highlights

Beringea LLP
Beringea LLC
ProVen VCT Plc

RelSci Relationships

1356

Number of Boards

13

Birthday

1959

Age

60

Contact Data
Trying to get in touch with Malcolm Kennedy Hunt Moss? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Malcolm Kennedy Hunt Moss likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Investment Officer at Beringea LLP

Relationship likelihood: Strong

Founder & Senior Managing Director at Beringea LLP

Relationship likelihood: Strong

Partner at Beringea LLP

Relationship likelihood: Strong

Partner at Beringea LLP

Relationship likelihood: Strong

Co-Founder at Beringea LLP

Relationship likelihood: Strong

Partner at Beringea LLP

Relationship likelihood: Strong

Managing Partner at Beringea LLP

Relationship likelihood: Strong

Chief Compliance Officer at Beringea LLP

Relationship likelihood: Strong

Partner (Growth Team) at Mobeus Equity Partners LLP

Relationship likelihood: Strong

Chief Executive Officer at INCONTEXT SOLUTIONS, INC.

Relationship likelihood: Strong

In The News
Crain's Detroit Business
April 27, 2015
Beringea backs U.K. med device biz looking to be local
Paths to Malcolm Kennedy Hunt Moss
Potential Connections via
Relationship Science
You
Malcolm Kennedy Hunt Moss
Founding Partner at Beringea LLP
Education
MBA

Kingston Business School is a school in London.

Career History
Founding Partner
2003 - Current

Beringea is an active manager which invests in dynamic businesses led by exceptional management in the healthcare, media, brands and intellectual property sectors, partnering with investee businesses to provide resources to develop strategy, evaluate growth opportunities, solve problems and build value.Their ProVen VCT invests in a diversified portfolio of unquoted and AIM-listed companies with the potential for significant value increases. After investing, the firm remains closely involved in the investee businesses, aiming to add value wherever possible and seeking to identify opportunities for profitable exits as the company's value increases. The firm's PGI VCT specializes in early-stage and growth company investments across a range of sectors.Beringea's InvestCare Partners, LP provides equity to medium-sized, privately owned mid- to late-stage US healthcare businesses, typically investing between $2 and $5 million.Their Global Rights Fund II invests in all growth stages of US and UK media, content, brands, enabling technology and intellectual property rights companies, seeking to exploit intellectual property rights across media platforms. Beringea typically invests $1-$5 million in Global Rights Fund II companies.

Principal
Prior

Baxter International Inc. (NYSE:BAX), through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter had 2011 sales of $13.9 billion and has approximately 48,500 employees.

Senior Strategist
Prior

Lloyds TSB is financial services group, which was created in 1995 following the merger of the TSB Group and the Lloyds Bank Group. Its businesses provides a range of banking and financial services in the United Kingdom and overseas, principally through branches of the Lloyds TSB Bank and its wholly owned subsidiaries, Cheltenham & Gloucester and Lloyds TSB Scotland. In 2000, Lloyds TSB Group acquired Scottish Widows. During 2003 and 2004, Lloyds TSB Group disposed of a number of its overseas operations, as part of the process of managing its portfolio of businesses to focus on its core markets

Boards & Committees
Non-Executive Director
2010 - Current

ProVen Planned Exit VCT Plc operates as a venture capital fund, which focuses on building a diversified portfolio of investments, primarily in United Kingdom based companies. It seeks to invest in sectors, such as health and education. The company was founded on August 2, 2010 and is headquartered in London, the United Kingdom.

Director
2010 - Current

Cogora Group Ltd. is a holding company, which is engaged in the provision of business to business information through magazines, events, research, and online portals. It serves the private wealth management and healthcare markets. The company was founded in 1987 and is headquartered in London, the United Kingdom.

Member, Board of Directors
2007 - Current

ProVen VCT Plc is a generalist fund. It invests in a diversified portfolio of the United Kingdom based unquoted companies. ProVen VCT was founded on January 18, 2000 and is headquartered in London, the United Kingdom.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Malcolm Kennedy Hunt Moss. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Malcolm Kennedy Hunt Moss's profile does not indicate a business or promotional relationship of any kind between RelSci and Malcolm Kennedy Hunt Moss.